UK Travel Vaccine Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Country Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel, and Outbound Travel)

No. of Pages: 122    |    Report Code: BMIRE00027328    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
UK Travel Vaccine Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. UK Travel Vaccine Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. UK Travel Vaccine Market – Key Market Dynamics

5.1 Growth Drivers
5.2 Market Opportunities
5.3 Future Trends
5.4 Impact of Drivers and Restraints

6. UK Travel Vaccine Market Regional Analysis

6.1 UK Travel Vaccine Market Overview
6.2 UK Travel Vaccine Market Revenue 2019-2028 (US$ Million)
6.3 UK Travel Vaccine Market Forecast Analysis

7. UK Travel Vaccine Market Analysis – by Product

7.1 Hepatitis A
  • 7.1.1 Overview
  • 7.1.2 Hepatitis A: UK Travel Vaccine Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Hepatitis B
  • 7.2.1 Overview
  • 7.2.2 Hepatitis B: UK Travel Vaccine Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Meningococcal Vaccines
  • 7.3.1 Overview
  • 7.3.2 Meningococcal Vaccines: UK Travel Vaccine Market – Revenue and Forecast to 2031 (US$ Million)

8. UK Travel Vaccine Market Analysis – by Application

8.1 Domestic Travel
  • 8.1.1 Overview
  • 8.1.2 Domestic Travel: UK Travel Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Outbound Travel
  • 8.2.1 Overview
  • 8.2.2 Outbound Travel : UK Travel Vaccine Market – Revenue and Forecast to 2028 (US$ Million)

9. UK Travel Vaccine Market – UK Analysis

9.1 UK
  • 9.1.1 UK Travel Vaccine Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 9.1.1.1 UK Travel Vaccine Market – Revenue and Forecast Analysis – by Country
  • 9.1.1.1 UK: UK Travel Vaccine Market – Revenue and Forecast to 2028 (US$ Million)
    • 9.1.1.1.1 UK: UK Travel Vaccine Market Breakdown, by Product
    • 9.1.1.1.2 UK: UK Travel Vaccine Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis
10.2 Company Positioning and Concentration

11. UK Travel Vaccine Market Industry Landscape

11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 GlaxoSmithKline plc.
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
12.2 Merck & Co., Inc.
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
12.3 Sanofi
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
12.4 Novartis AG
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
12.5 Pfizer Inc.
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
12.6 Dynavax Technologies
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
12.7 Emergent BioSolutions Inc.
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
12.8 Abbott
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
12.9 Valneva SE
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
12.10 SEQIRUS
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

13.1 About Business Market Insights

The List of Companies - UK Travel Vaccine Market

The List of Companies - UK Travel Vaccine Market
1. GlaxoSmithKline plc.
2. Merck & Co., Inc.
3. Sanofi
4. Novartis AG
5. Pfizer Inc.
6. Dynavax Technologies
7. Emergent BioSolutions Inc.
8. Abbott
9. Valneva SE
10. SEQIRUS